Zions Bancorporation, National Association’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$788K Sell
1,487
-1,464
-50% -$676K 0.05% 186
2026
Q1
$1.42M Sell
2,951
-1,935
-40% -$991K 0.09% 127
2025
Q4
$2.74M Sell
4,886
-1,189
-20% -$675K 0.13% 113
2025
Q3
$3.12M Sell
6,075
-904
-13% -$395K 0.15% 100
2025
Q2
$2.19M Sell
6,979
-1,915
-22% -$575K 0.12% 153
2025
Q1
$2.71M Buy
+8,894
New +$2.99M 0.17% 118

Other funds holding MEDP

Zions Bancorporation, National Association's MEDP Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Medpace (MEDP) stake by 50% in Q2 2026, selling an estimated $676K and leaving 1,487 shares worth $788K. The position accounts for 0.05% of the portfolio, ranked #186.

Zions Bancorporation, National Association first reported a position in MEDP in Q1 2025 and has held it in 6 quarters since. The position peaked at $3.12M in Q3 2025. 698 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Zions Bancorporation, National Association held 1,487 shares of Medpace worth $788K as of Q2 2026.
  • Zions Bancorporation, National Association sold 1,464 Medpace shares in Q2 2026, an estimated $676K.
  • Medpace made up 0.05% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #186 holding.
  • Zions Bancorporation, National Association first reported a position in Medpace in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Medpace position peaked at $3.12M in Q3 2025.
  • 698 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.